Literature DB >> 22419801

The magnitude of dengue virus NS1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model.

Satoru Watanabe1, Kah Hin Tan, Abhay P S Rathore, Kathryn Rozen-Gagnon, Wang Shuai, Christiane Ruedl, Subhash G Vasudevan.   

Abstract

There are conflicting data on the relationship between the level of secreted NS1 (sNS1), viremia, and disease severity upon dengue virus (DENV) infection in the clinical setting, and therefore, we examined this relationship in the widely accepted AG129 mouse model. Because of the failure of a routinely used NS1 detection kit to detect sNS1 of the mouse-adapted DENV2 strain, we screened 15 previously undescribed NS1 monoclonal antibodies and developed a robust capture enzyme-linked immunosorbent assay (ELISA) with detection sensitivity at the low nanogram level (0.2 ng/ml) using recombinant baculovirus-expressed sNS1 as well as sNS1 that was immunoaffinity purified from the various DENV2 strains employed in this study. Using this test, we demonstrated that increased viremia paralleled severe pathologies; however, sNS1 level did not correlate with viremia or severity. Furthermore, among the DENV2 strains that were tested, the level of NS1 secretion did not correspond to virus replication rate in vitro, at the cellular level. Together, our data indicate that the magnitude of NS1 secretion appears to be strain dependent and does not correlate with viral virulence in the AG129 mouse model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22419801      PMCID: PMC3347314          DOI: 10.1128/JVI.07081-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity.

Authors:  Prasad N Paradkar; Eng Eong Ooi; Brendon J Hanson; Duane J Gubler; Subhash G Vasudevan
Journal:  Biosci Rep       Date:  2011-06       Impact factor: 3.840

2.  Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.

Authors:  Raphaël M Zellweger; Tyler R Prestwood; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2010-02-18       Impact factor: 21.023

3.  A method for full genome sequencing of all four serotypes of the dengue virus.

Authors:  Joseph G Christenbury; Pauline P K Aw; Swee Hoe Ong; Mark J Schreiber; Angelia Chow; Duane J Gubler; Subhash G Vasudevan; Eng Eong Ooi; Martin L Hibberd
Journal:  J Virol Methods       Date:  2010-06-30       Impact factor: 2.014

4.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.

Authors:  Panisadee Avirutnan; Anja Fuchs; Richard E Hauhart; Pawit Somnuke; Soonjeon Youn; Michael S Diamond; John P Atkinson
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

6.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

7.  Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.

Authors:  Scott J Balsitis; Katherine L Williams; Ruben Lachica; Diana Flores; Jennifer L Kyle; Erin Mehlhop; Syd Johnson; Michael S Diamond; P Robert Beatty; Eva Harris
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

8.  Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis.

Authors:  Maria G Guzman; Thomas Jaenisch; Roger Gaczkowski; Vo Thi Ty Hang; Shamala Devi Sekaran; Axel Kroeger; Susana Vazquez; Didye Ruiz; Eric Martinez; Juan C Mercado; Angel Balmaseda; Eva Harris; Efren Dimano; Prisca Susan A Leano; Sutee Yoksan; Elci Villegas; Herminia Benduzu; Iris Villalobos; Jeremy Farrar; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

9.  Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status.

Authors:  Huynh T L Duyen; Tran V Ngoc; Do T Ha; Vu T T Hang; Nguyen T T Kieu; Paul R Young; Jeremy J Farrar; Cameron P Simmons; Marcel Wolbers; Bridget A Wills
Journal:  J Infect Dis       Date:  2011-02-18       Impact factor: 5.226

10.  Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum.

Authors:  Philippe Dussart; Laure Petit; Bhety Labeau; Laetitia Bremand; Alexandre Leduc; David Moua; Séverine Matheus; Laurence Baril
Journal:  PLoS Negl Trop Dis       Date:  2008-08-20
View more
  24 in total

1.  Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

Authors:  Satoru Watanabe; Kitti Wing Ki Chan; Jiaqi Wang; Laura Rivino; Shee-Mei Lok; Subhash G Vasudevan
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  The Limitation of Rapid Tests for DENV2 Infection in Host with Unique Immune Status: Low NS1 Antigenemia and Deficient Antibody Responses.

Authors:  Lei Yu; Yingfen Wen; Mengrong Xiang; Wenxin Hong; Lingzhai Zhao; Fuchun Zhang
Journal:  Virol Sin       Date:  2020-01-14       Impact factor: 4.327

3.  Tapered lateral flow immunoassay based point-of-care diagnostic device for ultrasensitive colorimetric detection of dengue NS1.

Authors:  Sanjay Kumar; Pulak Bhushan; Vinay Krishna; Shantanu Bhattacharya
Journal:  Biomicrofluidics       Date:  2018-05-14       Impact factor: 2.800

4.  Dengue virus-elicited tryptase induces endothelial permeability and shock.

Authors:  Abhay Ps Rathore; Chinmay Kumar Mantri; Siti Ab Aman; Ayesa Syenina; Justin Ooi; Cyril J Jagaraj; Chi Ching Goh; Hasitha Tissera; Annelies Wilder-Smith; Lai Guan Ng; Duane J Gubler; Ashley L St John
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

Review 5.  Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19.

Authors:  Yean Kong Yong; Won Fen Wong; Ramachandran Vignesh; Indranil Chattopadhyay; Vijayakumar Velu; Hong Yien Tan; Ying Zhang; Marie Larsson; Esaki M Shankar
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 6.  Secretion of Nonstructural Protein 1 of Dengue Virus from Infected Mosquito Cells: Facts and Speculations.

Authors:  Ana C Alcalá; Laura A Palomares; Juan E Ludert
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

7.  Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.

Authors:  Sergio I de la Cruz-Hernández; Hilario Flores-Aguilar; Silvia González-Mateos; Irma López-Martinez; Celia Alpuche-Aranda; Juan E Ludert; Rosa M del Angel
Journal:  Am J Trop Med Hyg       Date:  2013-01-21       Impact factor: 2.345

Review 8.  Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection.

Authors:  Yung-Chun Chuang; Shu-Ying Wang; Yee-Shin Lin; Hong-Ru Chen; Trai-Ming Yeh
Journal:  J Biomed Sci       Date:  2013-06-27       Impact factor: 8.410

9.  Reply to Halstead and Sayce et al.

Authors:  Dong Thi Hoai Tam; Cameron P Simmons; Bridget A Wills
Journal:  Clin Infect Dis       Date:  2012-12-14       Impact factor: 9.079

10.  Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2.

Authors:  Marlen Martinez-Gutierrez; Luis A Correa-Londoño; Jaime E Castellanos; Juan C Gallego-Gómez; Jorge E Osorio
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.